MARKET NEWS

Axol Bioscience & Censo Biotechnologies Announce Merger
ProBioGen Licenses GlymaxX Technology to Sanofi
Timber Pharmaceuticals Announces 50% Enrollment in Phase 2b CONTROL Study 
Owen Mumford Introduces 16-G Safety Lancet Into Unistik Touch Range for High-Volume Capillary Blood Sampling
FSD Pharma Enters License Agreement to Develop FDA-Approved Veterinary Drugs 
AC Immune Announces New Clinical Results in Down Syndrome, Plans for Future Development of Anti-Amyloid-Beta Vaccine

  FEATURED EDITORIAL

  COMPANY PROFILE

SGS Life Sciences is a leading contract service organization offering high quality analytical development, biologics characterization, utilities qualification, and quality control testing for over 40 years. Backed by a global network of testing facilities, we can help you to reduce risks, shorten time to market and demonstrate the quality and safety of your products. Our facilities utilize cutting-edge techniques and technologies and are staffed by knowledgeable and experienced personnel who stay abreast on the most recent developments in the field. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Micropore Appoints Technology Distributor for Japanese Market

Micropore Appoints Technology Distributor for Japanese Market

Award-winning UK-based particle engineering specialist Micropore Technologies has just announced the appointment of the Mutual Corporation as the representative for sales….

Aptar Pharma & Noble Partner With dne pharma on its Nasal Naloxone Treatment

Aptar Pharma & Noble Partner With dne pharma on its Nasal Naloxone Treatment

Aptar Pharma and Noble, an Aptar Pharma company, recently announced their collaboration with dne pharma. Both companies are providing their nasal drug delivery….

Hovione Completes its Phase 2 Clinical Trial of the First Minocycline Ophthalmic 

Hovione Completes its Phase 2 Clinical Trial of the First Minocycline Ophthalmic 

Hovione recently announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused….

Catalent Expands Partnership With Johnson & Johnson to Significantly Increase Capacity for Sterile Manufacturing & Packaging of COVID-19 Vaccine in Italy

Catalent Expands Partnership With Johnson & Johnson to Significantly Increase Capacity for Sterile Manufacturing & Packaging of COVID-19 Vaccine in Italy

Catalent recently announced an expanded partnership with Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent Biologics will significantly….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 31 – Polymers & Biomaterials
April 7 – Excipients